Hepatitis B vaccine patch study for healthy adults
Part of Digestive system, Infections clinical trials.
This trial tests a new way to give the hepatitis B vaccine using a patch applied to the skin, instead of a needle. It is for healthy adults aged 19 to 40 who have not already been vaccinated against hepatitis B.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 40 years old.
- You are generally healthy, based on a medical checkup and blood tests.
- You have never had the full hepatitis B vaccine series (except possibly as a baby).
- You do not have hepatitis B, C, or HIV.
- You are not pregnant and will not become pregnant or father a child during the study.
- Your body mass index (BMI) is between 18 and 30.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests whether a hepatitis B vaccine (with an added ingredient to boost the immune response) can safely help people with long-term hepatitis B who are already on antiviral therapy. It is mainly looking at safety and how the immune system responds.
This study is testing a new hepatitis B vaccine called SN2001 in healthy adults. It will check how safe the vaccine is, what dose works best, and how well it helps your body build protection against hepatitis B.
This trial tests an experimental antibody treatment for people with chronic hepatitis B who have been on antiviral medication for at least 6 months. It aims to see if the antibody is safe and can help control the virus.
This trial tests an experimental vaccine therapy to help control or possibly cure chronic hepatitis B. It is designed to see whether the treatment is safe and how well it affects the hepatitis B virus in adults.
This trial tests a new vaccine to treat chronic hepatitis B. It's for people who have been on antiviral medication for at least 6 months and still have a low level of the virus in their blood.
This study tests a new type of patch with tiny needles (microneedles) that delivers a tetanus vaccine booster through your skin instead of a traditional injection. Researchers want to confirm it's safe and works well in healthy adults.
Hear when a new Hepatitis B Vaccine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.